share_log

Teachers Retirement System of The State of Kentucky Sells 1,921 Shares of Masimo Co. (NASDAQ:MASI)

Teachers Retirement System of The State of Kentucky Sells 1,921 Shares of Masimo Co. (NASDAQ:MASI)

肯塔基州教师退休制度出售Masimo Co.(纳斯达克代码:MASI)1,921股
Defense World ·  2022/09/24 05:21

Teachers Retirement System of The State of Kentucky reduced its stake in shares of Masimo Co. (NASDAQ:MASI – Get Rating) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,826 shares of the medical equipment provider's stock after selling 1,921 shares during the quarter. Teachers Retirement System of The State of Kentucky's holdings in Masimo were worth $993,000 at the end of the most recent quarter.

根据肯塔基州教师退休系统公司向美国证券交易委员会(SEC)提交的最新Form 13F文件,该公司在第一季度减持了Masimo Co.(纳斯达克代码:MASI-GET评级)的股票22.0%。该基金在本季度出售了1,921股后,持有这家医疗设备提供商的6826股股票。肯塔基州教师退休制度在最近一个季度末,肯塔基州在马西莫的资产价值99.3万美元。

Several other hedge funds have also modified their holdings of the stock. BlackRock Inc. lifted its holdings in Masimo by 1.5% in the fourth quarter. BlackRock Inc. now owns 9,026,374 shares of the medical equipment provider's stock valued at $2,642,740,000 after buying an additional 133,072 shares during the period. Vanguard Group Inc. lifted its holdings in Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider's stock valued at $695,050,000 after buying an additional 71,918 shares during the period. State Street Corp lifted its holdings in Masimo by 1.6% in the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider's stock valued at $251,928,000 after buying an additional 27,261 shares during the period. RTW Investments LP lifted its holdings in Masimo by 32.7% in the first quarter. RTW Investments LP now owns 1,127,593 shares of the medical equipment provider's stock valued at $164,110,000 after buying an additional 277,622 shares during the period. Finally, Liontrust Investment Partners LLP acquired a new position in Masimo in the first quarter valued at approximately $146,646,000. 93.31% of the stock is owned by institutional investors.

其他几家对冲基金也调整了对该股的持有量。贝莱德股份有限公司去年第四季度增持马西莫股份1.5%。贝莱德股份有限公司目前持有这家医疗设备供应商9,026,374股股票,价值2,642,740,000美元,在此期间又购买了133,072股。先锋集团(Vanguard Group Inc.)第一季度增持Masimo股份1.5%。先锋集团现在持有这家医疗设备供应商4,775,660股股票,价值695,050,000美元,在此期间又购买了71,918股。道富银行在第一季度增持了1.6%的Masimo股份。道富集团目前持有这家医疗设备提供商1,730,991股股票,价值251,928,000美元,在此期间又购买了27,261股。RTW Investments LP在第一季度增持了32.7%的Masimo股份。RTW Investments LP现在拥有这家医疗设备提供商1,127,593股票,价值164,110,000美元,在此期间又购买了277,622股票。最后,LionTrust Investment Partners LLP在第一季度收购了Masimo的一个新头寸,价值约为146,646,000美元。93.31%的股票由机构投资者持有。

Get
到达
Masimo
马西莫
alerts:
警报:

Analyst Ratings Changes

分析师评级发生变化

MASI has been the topic of several analyst reports. Wolfe Research upgraded shares of Masimo from a "peer perform" rating to an "outperform" rating and set a $165.00 price objective on the stock in a report on Thursday, September 15th. StockNews.com lowered shares of Masimo from a "buy" rating to a "hold" rating in a report on Wednesday, August 10th. Piper Sandler raised their price objective on shares of Masimo from $135.00 to $150.00 and gave the stock a "neutral" rating in a report on Friday. Needham & Company LLC raised their price objective on shares of Masimo from $163.00 to $179.00 and gave the stock a "buy" rating in a report on Wednesday, August 10th. Finally, Loop Capital initiated coverage on shares of Masimo in a report on Tuesday, September 13th. They set a "buy" rating and a $206.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Masimo has an average rating of "Moderate Buy" and an average target price of $194.50.

马西一直是几份分析师报告的主题。沃尔夫研究公司在9月15日(星期四)的一份报告中将Masimo的股票评级从“同业表现”上调至“表现优于大盘”,并为该股设定了165.00美元的目标价。在8月10日星期三的一份报告中,StockNews.com将Masimo的股票评级从买入下调至持有。派珀·桑德勒在上周五的一份报告中将马西莫股票的目标价从135.00美元上调至150.00美元,并给予该股“中性”评级。Needham&Company LLC将Masimo的股票目标价从163.00美元上调至179.00美元,并在8月10日星期三的一份报告中给出了该股的“买入”评级。最后,Loop Capital在9月13日星期二的一份报告中启动了对Masimo股票的报道。他们为该股设定了“买入”评级和206.00美元的目标价。三位研究分析师对该股的评级为持有,五位分析师对该公司的评级为买入。根据MarketBeat的数据,Masimo的平均评级为“中等买入”,平均目标价为194.50美元.

Masimo Stock Down 0.1 %

Masimo股价下跌0.1%

Masimo stock opened at $142.28 on Friday. The company has a market cap of $7.47 billion, a P/E ratio of 42.86 and a beta of 0.96. Masimo Co. has a 1-year low of $112.07 and a 1-year high of $305.21. The company has a fifty day simple moving average of $149.18 and a 200 day simple moving average of $141.22. The company has a current ratio of 2.10, a quick ratio of 1.28 and a debt-to-equity ratio of 0.77.
上周五,马西莫的股票开盘报142.28美元。该公司市值为74.7亿美元,市盈率为42.86倍,贝塔系数为0.96。Masimo Co.的股价为一年低点112.07美元,一年高位为305.21美元。该公司的50日简单移动均线切入位为149.18美元,200日简单移动均线切入位为141.22美元。该公司的流动比率为2.10,速动比率为1.28,债务权益比率为0.77。

Masimo (NASDAQ:MASI – Get Rating) last announced its quarterly earnings data on Tuesday, August 9th. The medical equipment provider reported $1.35 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.16. Masimo had a net margin of 12.68% and a return on equity of 17.39%. The company had revenue of $565.30 million during the quarter, compared to the consensus estimate of $540.56 million. During the same quarter last year, the firm posted $0.94 EPS. The company's quarterly revenue was up 87.9% on a year-over-year basis. Research analysts anticipate that Masimo Co. will post 4.47 earnings per share for the current fiscal year.

马西莫(纳斯达克:MASI-GET评级)上一次公布季度收益数据是在8月9日(星期二)。这家医疗设备供应商公布本季度每股收益为1.35美元,比分析师普遍预期的1.19美元高出0.16美元。Masimo的净利润率为12.68%,股本回报率为17.39%。该公司本季度营收为5.653亿美元,而市场普遍预期为5.4056亿美元。去年同期,该公司公布的每股收益为0.94美元。该公司季度营收同比增长87.9%。研究分析师预计,Masimo Co.本财年每股收益将达到4.47欧元。

About Masimo

关于马西莫

(Get Rating)

(获取评级)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Masimo公司在全球开发、制造和营销非侵入性监测技术和医院自动化解决方案。该公司提供Masimo信号提取技术(SET)脉搏血氧仪和低灌注脉搏血氧仪监测,以解决传统脉搏血氧仪的主要局限性。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on Masimo (MASI)
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 2 Semiconductor Stocks To Watch For Reversals
  • 免费获取StockNews.com关于马西莫(Masi)的研究报告
  • MarketBeat:回顾一周9/19-9/23
  • 为什么特斯拉的股票保持弹性?
  • 好市多盈利后价格疲软是买入的好时机吗?
  • 小盘股的裁员是楼市的晴雨表吗?
  • 需要关注的2只半导体类股走势逆转

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

接受Masimo Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Masimo和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发